Patents by Inventor Kevin Paul

Kevin Paul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160156108
    Abstract: A wideband meander-line circular polariser includes a substrate and a plurality of parallel meander shaped conductors (meander lines). Each parallel meander line (20,30) is loaded with electrically isolated capacitive elements (40) enclosed within some or all of the individual meander loops, allowing the polariser to be made electrically smaller for a given wavelength whilst maintaining the desired resonant frequency. Multiple layers of the device ma be used.
    Type: Application
    Filed: July 9, 2014
    Publication date: June 2, 2016
    Inventors: KEVIN PAUL THOMAS, IVOR LESLIE MORROW
  • Patent number: 9342835
    Abstract: In one aspect, a system includes a transaction handler to process transactions, a data warehouse to store transaction data recording the transactions processed at the transaction handler, a profile generator to generate a profile of a user based on the transaction data, an advertisement selector to identify an advertisement based on the profile of the user in response to the transaction handler processing a transaction of the user, and a portal coupled to the transaction handler to provide the advertisement for presentation to the user in connection with information about the transaction of the user. In one example, the profile includes a plurality of values representing aggregated spending of the user in various areas to summarize the transactions of the user.
    Type: Grant
    Filed: August 3, 2010
    Date of Patent: May 17, 2016
    Assignee: VISA U.S.A
    Inventors: Edward W. Fordyce, III, Michelle Eng Winters, Kevin Paul Siegel, Leigh Amaro, Charles Raymond Byce, Nurtekin Savas
  • Publication number: 20160120849
    Abstract: A pharmaceutical combination comprising an EGFR inhibitor and an Hsp90 inhibitor according to the following formulae a tautomer, or a pharmaceutically acceptable salt thereof, wherein the variables in the structural formulae are defined herein. Also provided are methods for treating a proliferative disorder in a subject in need thereof using pharmaceutical combinations disclosed herein.
    Type: Application
    Filed: November 3, 2015
    Publication date: May 5, 2016
    Inventors: Ronald K. Blackman, Kevin Paul Foley, David Proia
  • Publication number: 20160102392
    Abstract: A ternary alloy wherein copper, manganese, and a ternary element are melted together and cast into an article and the article is subjected to an age-hardening treatment. A process for producing an age-hardened copper-manganese-nickel alloy, the process including melting a composition comprising copper, manganese and nickel; pouring the molten composition comprising copper, manganese, and nickel to form a casting with a composition comprising copper, manganese, and nickel, and aging the casting so produced. An article containing copper, manganese, and a ternary element, in a cast form and the cast form has subsequently undergone age-hardening treatment. A ternary alloy comprising copper, manganese, and a ternary element melted together and solidified into a casting, wherein the microstructure of the casting produced shows substantially low microporosity attributable to dendritic solidification.
    Type: Application
    Filed: October 10, 2015
    Publication date: April 14, 2016
    Applicant: PURDUE RESEARCH FOUNDATION
    Inventors: Kevin Paul Trumble, Kevin Joseph Chaput
  • Publication number: 20160094688
    Abstract: A network access device (NAD) receives a UDP packet from a client to be transmitted to a management server over Internet, the UDP packet including a management message. The NAD is one of NADs managed by the management server. The NAD determines whether the management server is reachable using a UDP protocol. The NAD transmits the UDP packet to the management server using the UDP protocol over the Internet if it is determined that the management server is reachable using the UDP protocol. Otherwise, the NAD extracts a UDP payload from the UDP packet, encapsulates the UDP payload within an HTTP POST request, and transmits the HTTP POST request having the UDP payload encapsulated therein to the management server using a HTTP protocol over the Internet.
    Type: Application
    Filed: December 9, 2015
    Publication date: March 31, 2016
    Inventors: Clifford A. Frey, John Bicket, Kevin Paul Herbert, Varun Sagar Malhotra, Benjamin A. Chambers
  • Publication number: 20160084796
    Abstract: Embodiments disclosed herein are directed to flow assays including at least one electrically-actuated valve configured to control fluid flow. Methods of operating such flow assays are also disclosed.
    Type: Application
    Filed: September 19, 2014
    Publication date: March 24, 2016
    Inventors: David Gasperino, Kevin Paul Flood Nichols, Benjamin K. Wilson, Ozgur Emek Yildirim
  • Publication number: 20160078987
    Abstract: An assembly has a two-stage cryogenic refrigerator and an associated mounting arrangement, and a sock having first and second stages corresponding to first and second stages of the refrigerator, with the first stage of the refrigerator being in thermal contact with the first stage of the sock and the second stage of the refrigerator being in thermal contact with the second stage of the sock.
    Type: Application
    Filed: April 17, 2014
    Publication date: March 17, 2016
    Applicant: SIEMENS PLC
    Inventors: MICHAEL SIMPKINS, NEIL CHARLES TIGWELL, KEVIN PAUL WASTIE
  • Publication number: 20160018811
    Abstract: A method for controlling flow localization in machining process is disclosed. By application of a constraint of sufficient level in the deformation zone and modifying the surface boundary conditions, suppression of unsteady flow and flow instabilities is achieved. The method enhances machined component quality by ensuring a uniform deformation state on the machined surface. Machined components are produced by ensuing uniform deformation by adopting constrained-cutting process for suppressing the instabilities and unsteady flow through a pre-determined location of the constraint of the constrained machining process relative to the machining tool.
    Type: Application
    Filed: July 17, 2015
    Publication date: January 21, 2016
    Applicant: Purdue Research Foundation
    Inventors: Dinakar Sagapuram, Kevin Paul Trumble, Walter Dale Compton, Srinivasan Chandrasekar
  • Patent number: 9233859
    Abstract: The present invention provides a system for solvent extraction utilizing a first electrode with a raised area formed on its surface, which defines a portion of a microfluidic channel; a second electrode with a flat surface, defining another portion of the microfluidic channel that opposes the raised area of the first electrode; a reversibly deformable substrate disposed between the first electrode and second electrode, adapted to accommodate the raised area of the first electrode and having a portion that extends beyond the raised area of the first electrode, that portion defining the remaining portions of the microfluidic channel; and an electrolyte of at least two immiscible liquids that flows through the microfluidic channel. Also provided is a system for performing multiple solvent extractions utilizing several microfluidic chips or unit operations connected in series.
    Type: Grant
    Filed: October 30, 2013
    Date of Patent: January 12, 2016
    Assignee: UCHICAGO ARGONNE, LLC.
    Inventors: Artem Gelis, Candido Pereira, Kevin Paul Flood Nichols
  • Publication number: 20160000756
    Abstract: Compounds of formula (I), pharmaceutical compositions comprising compounds of formula (I) and methods of inhibiting Hsp90 in a cell, treating or preventing a proliferation disorder in a mammal and treating cancer in a mammal comprising administering a compound of formula (I) to a patient or a cell. Variable R5 is an optionally substituted heteroaryl; an optionally substituted 6 to 14-membered aryl; a bicyclic 9-member heterocycle optionally substituted at any substitutable nitrogen or carbon atoms; or a substituent R18, defined herein. Ring A is an aryl or a heteroaryl optionally further substituted with one or more substituents in addition to R3. Substituent R3 is defined herein.
    Type: Application
    Filed: July 13, 2015
    Publication date: January 7, 2016
    Inventors: Weiwen Ying, Zhenjian Du, Kevin Paul Foley
  • Patent number: 9215131
    Abstract: A network access device (NAD) receives a UDP packet from a client to be transmitted to a management server over Internet, the UDP packet including a management message. The NAD is one of NADs managed by the management server. The NAD determines whether the management server is reachable using a UDP protocol. The NAD transmits the UDP packet to the management server using the UDP protocol over the Internet if it is determined that the management server is reachable using the UDP protocol. Otherwise, the NAD extracts a UDP payload from the UDP packet, encapsulates the UDP payload within an HTTP POST request, and transmits the HTTP POST request having the UDP payload encapsulated therein to the management server using a HTTP protocol over the Internet.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: December 15, 2015
    Assignee: CISCO TECHNOLOGY, INC.
    Inventors: Clifford A. Frey, John Bicket, Kevin Paul Herbert, Varun Sagar Malhotra, Benjamin A. Chambers
  • Patent number: 9205086
    Abstract: A pharmaceutical combination comprising an EGFR inhibitor and an Hsp90 inhibitor according to the following formulae (I) or (Ia) a tautomer, or a pharmaceutically acceptable salt thereof, wherein the variables in the structural formulae are defined herein. Also provided are methods for treating a proliferative disorder in a subject in need thereof using pharmaceutical combinations disclosed herein.
    Type: Grant
    Filed: April 19, 2011
    Date of Patent: December 8, 2015
    Assignee: Synta Pharmaceuticals Corp.
    Inventors: Ronald K. Blackman, Kevin Paul Foley, David Proia
  • Patent number: 9206162
    Abstract: The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
    Type: Grant
    Filed: April 13, 2015
    Date of Patent: December 8, 2015
    Assignee: Synta Pharmaceuticals Corp.
    Inventors: Lijun Sun, Weiwen Ying, Junghyun Chae, Teresa Kowalczyk-Przewloka, Shijie Zhang, Dinesh U. Chimmanamada, Kevin Paul Foley, Zhenjian Du, Hao Li, David James, Howard P. Ng, Zachary Demko, Dan Zhou, Shuzhen Qin
  • Patent number: 9161080
    Abstract: Embodiments herein include methods and systems for use in delivering resources to a client device over a local network. An exemplary system comprises a plurality of caching devices operable to cache resources on behalf of a plurality of content providers, and a local caching device communicatively situated between an access network and the client device, wherein the access network is communicably situated between the plurality of caching devices and the local caching device. The local caching device is operable to retrieve a requested resource from at least one of the plurality of caching devices, deliver the requested resource to the client device over the local network, and store the requested resource for future requests by other client devices.
    Type: Grant
    Filed: July 12, 2012
    Date of Patent: October 13, 2015
    Assignee: LEVEL 3 COMMUNICATIONS, LLC
    Inventors: James Q. Crowe, John F. Waters, Jr., Andrew Dugan, Christopher Newton, Laurence Lipstone, Kenneth Brookman, Joseph Lawrence, Andrew Swart, David Fullagar, Kevin Paul, Mark Taylor
  • Patent number: 9156794
    Abstract: Compounds of formula (I), pharmaceutical compositions comprising compounds of formula (I) and methods of inhibiting Hsp90 in a cell, treating or preventing a proliferation disorder in a mammal and treating cancer in a mammal comprising administering a compound of formula (I) to a patient or a cell. Variable R5 is an optionally substituted heteroaryl; an optionally substituted 6 to 14-membered aryl; a bicyclic 9-member heterocycle optionally substituted at any substitutable nitrogen or carbon atoms; or a substituent R18, defined herein. Ring A is an aryl or a heteroaryl optionally further substituted with one or more substituents in addition to R3. Substituent R3 is defined herein.
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: October 13, 2015
    Assignee: Synta Pharmaceuticals Corp.
    Inventors: Weiwen Ying, Zhenjian Du, Kevin Paul Foley
  • Publication number: 20150266858
    Abstract: The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
    Type: Application
    Filed: April 13, 2015
    Publication date: September 24, 2015
    Inventors: Lijun Sun, Weiwen Ying, Junghyun Chae, Teresa Kowalczyk-Przewloka, Shijie Zhang, Dinesh U. Chimmanamada, Kevin Paul Foley, Zhenjian Du, Hao Li, David James, Howard P. Ng, Zachary Demko, Dan Zhou, Shuzhen Qin
  • Patent number: 9108933
    Abstract: The present invention relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for treating c-Met associated cancers, in a subject in need thereof.
    Type: Grant
    Filed: February 10, 2014
    Date of Patent: August 18, 2015
    Assignee: Synta Pharmaceuticals Corp.
    Inventors: Zhenjian Du, Kevin Paul Foley
  • Publication number: 20150227936
    Abstract: A system for providing real-time risk mitigation for an authorization system. The system receives authorization requests from multiple merchants (or their respective acquirers) and processes such requests. Each processed request is then forwarded to its corresponding issuer for further authorization. Each processed request includes an authorization message. The authorization message can include a risk score, a number of reason codes, and a number of condition codes. The use of the risk score, reason codes and condition codes allows issuers to make better informed decisions with respect to providing authorizations.
    Type: Application
    Filed: April 21, 2015
    Publication date: August 13, 2015
    Inventors: Belva J. Bruesewitz, Nancy Hilgers, Patrick L. Faith, Kevin Paul Siegel, Xiaoli Li, Krishna Prasad Koganti, Craig O'Connell
  • Publication number: 20150182936
    Abstract: Systems and methods for synthesizing high-quality nanocrystals via segmented, continuous flow microwave-assisted reactor were developed.
    Type: Application
    Filed: December 24, 2014
    Publication date: July 2, 2015
    Inventors: Ki-Joong Kim, Eric Bradley Hostetler, Gregory Scott Herman, Daniel Alan Peterson, Chih-hung Chang, Brendan Thomas Flynn, Brian Kevin Paul, Richard Paul Oleksak, Padmavathi Chandran, Bob C. Fitzmorris, Gustavo Henrique Albuquerque
  • Patent number: D756752
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: May 24, 2016
    Inventor: Kevin Paul Dentener